Loading clinical trials...
Loading clinical trials...
Oral Dydrogesterone Versus Micronized Vaginal Progesterone for Luteal Phase Support in In Vitro Fertilisation (IVF)/ IntraCytoplasmic Sperm Injection (ICSI): Pharmacokinetics and the Impact on the Endometrium, the Microbiota of the Genital Tract and the Peripheral Immunology. Double Blind Crossover Study.
Conditions
Interventions
Dydrogesterone Oral Tablet
Micronized progesterone
+2 more
Locations
1
Belgium
Centrum voor Reproductieve Geneeskunde
Jette, Brussels Capital, Belgium
Start Date
May 1, 2019
Primary Completion Date
August 24, 2020
Completion Date
August 24, 2020
Last Updated
December 17, 2020
NCT07542626
NCT06190899
NCT06826365
NCT07340827
NCT07471373
NCT07153367
Lead Sponsor
CRG UZ Brussel
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions